Drug firm

药品公司

Pfizer

辉瑞

on Monday said it has launched its next-generation 20-valent pneumococcal conjugate vaccine (

周一表示，已推出其下一代 20 价肺炎球菌结合疫苗 (

PCV20

PCV20

) for adults in India.

) 适用于印度的成年人。

The vaccine helps protect against clinically relevant 20 serotypes responsible for a majority of invasive and non-invasive

该疫苗有助于预防由大多数侵袭性和非侵袭性疾病相关的20种临床相关血清型。

pneumococcal disease

肺炎球菌病

, it said in a statement.

，声明中说道。

Finance

金融

Value and Valuation Masterclass Batch-1

价值与估值大师班第一期

By CA Himanshu Jain

作者：CA希曼舒·贾恩

View Program

查看程序

Finance

金融

Value and Valuation Masterclass - Batch 2

价值与估值大师班 - 第2批

By CA Himanshu Jain

作者：CA希曼舒·贾恩

View Program

查看程序

Finance

金融

Value and Valuation Masterclass - Batch 3

价值与估值大师班 - 第3期

By CA Himanshu Jain

作者：CA Himanshu Jain

View Program

查看程序

Artificial Intelligence

人工智能

AI For Business Professionals

商务人士的人工智能

By Vaibhav Sisinity

作者：Vaibhav Sisinity

View Program

查看程序

Finance

金融

Value and Valuation Masterclass - Batch 4

价值与估值大师班 - 第4批次

By CA Himanshu Jain

作者：CA希曼舒·贾恩

View Program

查看程序

Artificial Intelligence

人工智能

AI For Business Professionals Batch 2

商务专业人士人工智能培训 第2期

By Ansh Mehra

作者：安什·梅赫拉

View Program

查看程序

It enables timely and proactive protection for all adults, including those living with chronic conditions, it added.

它补充说，它为所有成年人，包括那些患有慢性病的人，提供了及时和主动的保护。

PCV20 will be available as a single-shot vaccine and those vaccinated with PCV20 may not need a second dose, the drug maker said.

药品制造商表示，PCV20 将作为单剂疫苗提供，接种 PCV20 的人可能不需要第二剂。

'We believe this vaccine, with its broad coverage of 20 pneumococcal disease serotypes, will address the increasing need for

“我们相信这种疫苗能够覆盖20种肺炎球菌病血清型，将满足日益增长的需求。

adult immunisation

成人免疫接种

in our country,' Pfizer MD Meenakshi Nevatia said. PTI

在我国，辉瑞总经理米纳克希·内瓦蒂亚表示。PTI

(You can now subscribe to our

（您现在可以订阅我们的

Economic Times WhatsApp channel

经济时报WhatsApp频道

)

)

(You can now subscribe to our

（您现在可以订阅我们的

Economic Times WhatsApp channel

经济时报WhatsApp频道

)

)